Radioligand Therapy Market Size, Share & Trends Analysis Report By Isotope (Lutetium-177 (Lu-177), Actinium-225 (Ac-225), Iodine-131 (I-131), Other Isotopes), By Target (Prostate-Specific Membrane Antigen, Ki 67 Expression and Grading, Cytochrome P450 17A1 Inhibitor), By Indication (Prostate Cancer, Neuroendocrine Tumours (NETs), Others), By End-User (Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 18, 2026 | Author: Dhanashri B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Radioligand Therapy Market Size Analysis
    1. Introduction
    2. Radioligand Therapy Market Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
      1. Lutetium-177 (Lu-177)
      2. Actinium-225 (Ac-225)
      3. Iodine-131 (I-131)
      4. Other Isotopes
    3. Radioligand Therapy Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. Prostate-Specific Membrane Antigen
      2. Ki 67 Expression and Grading
      3. Cytochrome P450 17A1 Inhibitor
    4. Radioligand Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Neuroendocrine Tumours (NETs)
      3. Others
    5. Radioligand Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Treatment Centers
      4. Others
  7. North America Radioligand Therapy Market Size Analysis
    1. Introduction
    2. Radioligand Therapy Market Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
      1. Lutetium-177 (Lu-177)
      2. Actinium-225 (Ac-225)
      3. Iodine-131 (I-131)
      4. Other Isotopes
    3. Radioligand Therapy Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. Prostate-Specific Membrane Antigen
      2. Ki 67 Expression and Grading
      3. Cytochrome P450 17A1 Inhibitor
    4. Radioligand Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Neuroendocrine Tumours (NETs)
      3. Others
    5. Radioligand Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Treatment Centers
      4. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
  8. Europe Radioligand Therapy Market Size Analysis
    1. Introduction
    2. Radioligand Therapy Market Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
      1. Lutetium-177 (Lu-177)
      2. Actinium-225 (Ac-225)
      3. Iodine-131 (I-131)
      4. Other Isotopes
    3. Radioligand Therapy Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. Prostate-Specific Membrane Antigen
      2. Ki 67 Expression and Grading
      3. Cytochrome P450 17A1 Inhibitor
    4. Radioligand Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Neuroendocrine Tumours (NETs)
      3. Others
    5. Radioligand Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Treatment Centers
      4. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
  9. APAC Radioligand Therapy Market Size Analysis
    1. Introduction
    2. Radioligand Therapy Market Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
      1. Lutetium-177 (Lu-177)
      2. Actinium-225 (Ac-225)
      3. Iodine-131 (I-131)
      4. Other Isotopes
    3. Radioligand Therapy Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. Prostate-Specific Membrane Antigen
      2. Ki 67 Expression and Grading
      3. Cytochrome P450 17A1 Inhibitor
    4. Radioligand Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Neuroendocrine Tumours (NETs)
      3. Others
    5. Radioligand Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Treatment Centers
      4. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
  10. Middle East and Africa Radioligand Therapy Market Size Analysis
    1. Introduction
    2. Radioligand Therapy Market Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
      1. Lutetium-177 (Lu-177)
      2. Actinium-225 (Ac-225)
      3. Iodine-131 (I-131)
      4. Other Isotopes
    3. Radioligand Therapy Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. Prostate-Specific Membrane Antigen
      2. Ki 67 Expression and Grading
      3. Cytochrome P450 17A1 Inhibitor
    4. Radioligand Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Neuroendocrine Tumours (NETs)
      3. Others
    5. Radioligand Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Treatment Centers
      4. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
  11. LATAM Radioligand Therapy Market Size Analysis
    1. Introduction
    2. Radioligand Therapy Market Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
      1. Lutetium-177 (Lu-177)
      2. Actinium-225 (Ac-225)
      3. Iodine-131 (I-131)
      4. Other Isotopes
    3. Radioligand Therapy Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. Prostate-Specific Membrane Antigen
      2. Ki 67 Expression and Grading
      3. Cytochrome P450 17A1 Inhibitor
    4. Radioligand Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Prostate Cancer
      2. Neuroendocrine Tumours (NETs)
      3. Others
    5. Radioligand Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Treatment Centers
      4. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Isotope 2022-2034 (USD MILLION/ Units)
        1. Lutetium-177 (Lu-177)
        2. Actinium-225 (Ac-225)
        3. Iodine-131 (I-131)
        4. Other Isotopes
      3. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. Prostate-Specific Membrane Antigen
        2. Ki 67 Expression and Grading
        3. Cytochrome P450 17A1 Inhibitor
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Prostate Cancer
        2. Neuroendocrine Tumours (NETs)
        3. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Cancer Treatment Centers
        4. Others
  12. Competitive Landscape
    1. Radioligand Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Clovis Oncology
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Curium Pharma
    3. Amneal Pharmaceuticals LLC
    4. Novartis AG
    5. Molecular Partners
    6. Pfizer Inc.
    7. Eli Lilly and Company (POINT Biopharma Global Inc.)
    8. Fusion Pharmaceuticals Inc.
    9. Telix Pharmaceuticals
    10. Lantheus Holdings Inc.
    11. Bayer AG
    12. ITM Isotope Technologies Munich SE
    13. Precirix
    14. Radio Medix
    15. Johnson & Johnson Services Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Radioligand Therapy Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 3: Global Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 4: Global Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 5: Global Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 6: North America Radioligand Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 7: North America Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 8: North America Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 9: North America Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 10: North America Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 11: U.S. Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 12: U.S. Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 13: U.S. Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 14: U.S. Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 15: Canada Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 16: Canada Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 17: Canada Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 18: Canada Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 19: Europe Radioligand Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 20: Europe Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 21: Europe Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 22: Europe Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 23: Europe Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 24: U.K. Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 25: U.K. Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 26: U.K. Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 27: U.K. Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 28: Germany Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 29: Germany Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 30: Germany Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 31: Germany Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 32: France Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 33: France Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 34: France Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 35: France Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 36: Spain Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 37: Spain Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 38: Spain Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 39: Spain Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 40: Italy Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 41: Italy Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 42: Italy Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 43: Italy Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 44: Russia Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 45: Russia Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 46: Russia Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 47: Russia Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 48: Nordic Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 49: Nordic Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 50: Nordic Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 51: Nordic Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 52: Benelux Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 53: Benelux Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 54: Benelux Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 55: Benelux Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 56: Rest of Europe Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 57: Rest of Europe Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 58: Rest of Europe Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 59: Rest of Europe Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 60: APAC Radioligand Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 61: APAC Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 62: APAC Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 63: APAC Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 64: APAC Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 65: China Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 66: China Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 67: China Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 68: China Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 69: Korea Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 70: Korea Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 71: Korea Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 72: Korea Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 73: Japan Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 74: Japan Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 75: Japan Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 76: Japan Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 77: India Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 78: India Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 79: India Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 80: India Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 81: Australia Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 82: Australia Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 83: Australia Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 84: Australia Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 85: Taiwan Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 86: Taiwan Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 87: Taiwan Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 88: Taiwan Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 89: South East Asia Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 90: South East Asia Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 91: South East Asia Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 92: South East Asia Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 93: Rest of Asia-Pacific Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 94: Rest of Asia-Pacific Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 95: Rest of Asia-Pacific Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 96: Rest of Asia-Pacific Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 97: Middle East and Africa Radioligand Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 98: Middle East and Africa Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 99: Middle East and Africa Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 100: Middle East and Africa Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 101: Middle East and Africa Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 102: UAE Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 103: UAE Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 104: UAE Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 105: UAE Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 106: Turkey Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 107: Turkey Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 108: Turkey Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 109: Turkey Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 110: Saudi Arabia Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 111: Saudi Arabia Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 112: Saudi Arabia Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 113: Saudi Arabia Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 114: South Africa Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 115: South Africa Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 116: South Africa Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 117: South Africa Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 118: Egypt Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 119: Egypt Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 120: Egypt Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 121: Egypt Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 122: Nigeria Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 123: Nigeria Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 124: Nigeria Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 125: Nigeria Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 126: Rest of MEA Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 127: Rest of MEA Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 128: Rest of MEA Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 129: Rest of MEA Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 130: LATAM Radioligand Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 131: LATAM Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 132: LATAM Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 133: LATAM Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 134: LATAM Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 135: Brazil Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 136: Brazil Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 137: Brazil Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 138: Brazil Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 139: Mexico Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 140: Mexico Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 141: Mexico Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 142: Mexico Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 143: Argentina Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 144: Argentina Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 145: Argentina Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 146: Argentina Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 147: Chile Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 148: Chile Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 149: Chile Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 150: Chile Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 151: Colombia Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 152: Colombia Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 153: Colombia Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 154: Colombia Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

Table 155: Rest of LATAM Radioligand Therapy Market Size and Forecast By Isotope - 2022-2034 (USD Billion)

Table 156: Rest of LATAM Radioligand Therapy Market Size and Forecast By Target - 2022-2034 (USD Billion)

Table 157: Rest of LATAM Radioligand Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 158: Rest of LATAM Radioligand Therapy Market Size and Forecast By End-User - 2022-2034 (USD Billion)

We are featured on: